Glaucoma, Vision & Longevity: Supplements & Science

Astaxanthin for Oxidative Stress and Ocular Blood Flow

Visual Field Test

This audio article is from VisualFieldTest.com.

Read the full article here: https://visualfieldtest.com/en/astaxanthin-for-oxidative-stress-and-ocular-blood-flow

Test your visual field online: https://visualfieldtest.com

Excerpt:

Astaxanthin: A Potent Antioxidant for Eye HealthOxidative stress – an imbalance between reactive oxygen species (ROS) and the body’s defenses – contributes to many eye diseases (dry eye, macular degeneration, glaucoma, cataract) () (). Astaxanthin (AXT) is a red xanthophyll carotenoid found in algae and seafood (salmon, shrimp). Its unique structure (polar ends and a long conjugated chain) allows it to span cell membranes, scavenging free radicals (ROS) both inside and outside cells () (). Unlike routine antioxidants (vitamin C/E), AXT crosses membranes and even the blood–brain barrier, making it exceptionally potent. It is noted for strong antioxidant, anti-inflammatory, and anti-apoptotic activities () (). These properties make AXT a candidate for protecting ocular tissues. Recent studies suggest AXT can modulate eye metabolism and inflammation, potentially improving vision and eye comfort () (). Antioxidant and Anti-Inflammatory Effects in Ocular TissuesAstaxanthin protects eye cells from oxidative damage. In animal models of eye disease, AXT reduced markers of stress and inflammation in the retina and cornea. For example, in diabetic rats, orally given AXT suppressed expression of inflammatory molecules (e.g. NF-κB) and oxidative stress in the retina () (). In a mouse glaucoma model (acute high eye pressure), AXT preserved retinal ganglion cells by boosting the Nrf2/HO-1 antioxidant pathway and reducing apoptosis (). In a rat glaucoma model, AXT lowered retinal protein oxidation and nitric oxide synthase-2 (NOS-2), markers of damage, and reduced cell death () (). These studies show that AXT’s free-radical scavenging stabilizes crucial eye cells under stress. In more routine settings, AXT also benefits ocular surface and lens tissues. For example, some clinical trials have used AXT to ease digital eye strain or dry eye symptoms, arguing that its anti-inflammatory action (e.g. lowering NF-κB in ciliary body) and improved microcirculation can relieve fatigue (). In one trial of visual display terminal (computer) users, AXT supplements (with other antioxidants) significantly improved blink rates and tear-film stability. Overall, AXT’s antioxidant and anti-inflammatory effects appear to help maintain normal ocular function and comfort () (). Accommodative Function and Eye StrainAccommodation is the eye’s ability to focus on near objects, using the ciliary muscle to change lens shape. In ageing or after prolonged screen use, accommodation can become sluggish, leading to eyestrain (asthenopia). Several studies report that AXT may improve accommodation. In healthy adults over 40, 4–12 mg of AXT daily for 4 weeks improved visual acuity and shortened accommodation time (faster focus) (). In a combined supplement trial, middle-aged adults who took AXT (with lutein, DHA, etc.) for 4 weeks showed better near-point accommodation and found tasks “trouble-free” (less neck strain and blurring) compared to placebo (). The proposed mechanism is that AXT relaxes the ciliary muscle and enhances blood flow around the lens and retina (). A dedicated 6-week trial (9 mg/day AXT) found that among adults ≥40, the astaxanthin group maintained better corrected visual acuity after 6 hours of screen use than placebo (). In other words, AXT helped older eyes resist the temporary blurring caused by prolonged near work. No change was seen in younger adults (as their ciliary function is already strong). These findings suggest AXT’s antioxidant protection helps the aging ciliary muscle sustain focus under stress (). Ov